2024 Distinguished Scientist Jane W. Newburger, MD, MPH, FAHA


Jane Newburger

Jane W. Newburger, MD, MPH, FAHA
Harvard Medical School
Boston, Massachusetts

Jane W. Newburger, MD, MPH, FAHA is the Commonwealth Professor of Pediatrics at Harvard Medical School and Associate Cardiologist-in-Chief for Academic Affairs at Boston Children’s Hospital. An international authority in pediatric cardiovascular disease, her research has focused on clinical outcomes and neurodevelopment in congenital heart disease, Kawasaki disease, and the multisystem inflammatory syndrome in children.

She has published over 600 peer-reviewed manuscripts, reviews, and chapters. A member of the National Academy of Medicine, she has received the Distinguished Scientist Award (Clinical) of the American College of Cardiology (ACC), the Clinical Research Prize of the American Heart Association (AHA), the AHA Council Meritorious Achievement Award, the AHA Paul Dudley White Award, and the Founder’s Award of the American Academy of Pediatrics (AAP).

She has served on the NHLBI Advisory Council, leadership councils in the AAP, ACC, and AHA, and the Board of Trustees of the ACC. She previously chaired the Clinical Science Subcommittee of the NHLBI Task Force on Pediatric Cardiovascular Disease and the AHA Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee. She is a former Associate Editor and then Senior Editor of Circulation and currently serves on an array of journal editorial boards.

She has mentored generations of trainees and junior faculty; is a longstanding PI of a T32 award in pediatric cardiovascular research; and received both the Harvard Medical School’s Silen Lifetime Mentoring Award and the Joseph P. Martin Award for the Advancement of Women Faculty. Continuously funded by the NIH since 1982, her weighted Relative Citation ratio is 2250, and she has 33 published manuscripts above the 99th NIH percentile for citation.

In addition to her research, Dr. Newburger maintains a busy clinical practice comprised of patients with congenital and acquired heart disease, keeping her “grounded” regarding important issues affecting the well-being of children with heart disease.